Found 7 matching trials
Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma
PHASE2The purpose of the study is to evaluate the efficacy and safety of rezvilut...
Location
Peking University First Hospital
Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy
PHASE2Prostate cancer patients with high-risk features who undergo radical prosta...
Location
Nanjing Drum Tower Hospital, Affilitated Hospital of Medical School, Nanjing University
A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
PHASE3This study aims to compare the efficacy and safety of rezvilutamide with en...
Location
The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
PHASE2This is a prospective, multicenter, multi-arm, non-randomized, open-label c...
Location
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University
Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate Cancer
PHASE2This multicenter, prospective, cohort study enrolled patients with metastat...
Location
Multiple Locations
Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC
PHASE3Evaluate whether the combination of Rezvilutamide and androgen deprivation ...
Location
Urology dpt, First Affiliated Hospital of Nanjing Medical University
A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer
PHASE1The study aims to assess the safety and tolerability of SHR-4394 in combina...
Location
West China Hospital of Sichuan University